This is the authors' abstract. We don't add key points for this paper.
The study was carried out to identify factors affecting the life expectancy of patients with viral hepatitis in areas with low population density. Methods . Medical records of 30 patients died from viral hepatitis B and/or C in Kamchatskiy kray were studied retrospectively. Life expectancy (LE) from disease detection to lethal outcome was assessed. R-statistics was used to identify factors associated with LE. Results . The median life expectancy of these patients is associated with non-modifiable factors: gender (women – 9 years, men – 3 years) and type of virus (HBV – 13 years, HCV– 5 years, B+C coinfection – 3 years), as well as modifiable factors: alcohol consumption during treatment (for those who drank alcohol – 3 years, for those who did not drink – 9 years), antiviral therapy (for those who received treatment – 12 years, those who did not – 2 years). Conclusion . Measures to provide antiviral treatment and to prevent alcohol use for patients with viral hepatitis C should be prioritized in areas with low population densities.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Gromov et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: